Vaccine for ovarian cancer has scientists ‘optimistic’ about eradicating disease

Published



The world’s first ovarian cancer vaccine has been awarded research funding in the United Kingdom, marking the first step toward a groundbreaking preventive measure that scientists say could eliminate the disease entirely.

OvarianVax is being developed by scientists at the University of Oxford. Cancer Research U.K. awarded the team on Friday with up to $790,000 over the next three years.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.